Abiopharma

Johnson Controls étend sa présence en Europe avec louverture de nouveaux centres dingénierie, de production et de service à la clientèle au Danemark USA - Français USA - English

Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026

Halozyme - HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE

Forte Biosciences Inc - Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

aTyr Pharma Provides Regulatory and Clinical Update for Efzofitimod in Pulmonary Sarcoidosis Following FDA Type C Meeting

Erasca Reports First Quarter 2026 Business Updates and Financial Results

Dynex Capital, Inc. Declares Monthly Common Stock Dividend of $0.17

コーペイ、BVNKとの提携により世界中の顧客向けにステーブルコイン・ウォレットを追加

Corpay与BVNK达成合作，为全球客户新增稳定币钱包服务

Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates